ImmuCell Corp
NASDAQ:ICCC
Balance Sheet
Balance Sheet Decomposition
ImmuCell Corp
Current Assets | 11.5m |
Cash & Short-Term Investments | 978.7k |
Receivables | 2.2m |
Other Current Assets | 8.3m |
Non-Current Assets | 32.3m |
PP&E | 32.1m |
Intangibles | 133.8k |
Other Non-Current Assets | 57.7k |
Current Liabilities | 4.2m |
Accounts Payable | 887.7k |
Accrued Liabilities | 1.7m |
Other Current Liabilities | 1.6m |
Non-Current Liabilities | 14.6m |
Long-Term Debt | 10.5m |
Other Non-Current Liabilities | 4.1m |
Balance Sheet
ImmuCell Corp
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1
|
2
|
5
|
4
|
3
|
6
|
7
|
10
|
6
|
1
|
|
Cash Equivalents |
1
|
2
|
5
|
4
|
3
|
6
|
7
|
10
|
6
|
1
|
|
Short-Term Investments |
2
|
4
|
5
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
Total Receivables |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
|
Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
1
|
1
|
2
|
2
|
2
|
3
|
2
|
3
|
6
|
8
|
|
Other Current Assets |
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
5
|
8
|
14
|
8
|
6
|
13
|
12
|
16
|
14
|
11
|
|
PP&E Net |
4
|
6
|
10
|
26
|
26
|
25
|
28
|
28
|
31
|
32
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
25
|
28
|
28
|
31
|
32
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
10
|
12
|
14
|
16
|
18
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
11
N/A
|
15
+32%
|
25
+70%
|
34
+39%
|
33
-5%
|
39
+18%
|
40
+4%
|
44
+10%
|
45
+1%
|
44
-2%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
1
|
1
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
4
|
|
Long-Term Debt |
1
|
3
|
3
|
9
|
8
|
7
|
9
|
8
|
9
|
11
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
|
Total Liabilities |
2
N/A
|
4
+120%
|
5
+27%
|
11
+115%
|
11
+3%
|
10
-12%
|
12
+25%
|
12
-2%
|
14
+22%
|
19
+30%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Retained Earnings |
1
|
1
|
1
|
1
|
1
|
3
|
4
|
4
|
6
|
12
|
|
Additional Paid In Capital |
10
|
10
|
19
|
22
|
23
|
31
|
31
|
36
|
36
|
36
|
|
Treasury Stock |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
9
N/A
|
11
+15%
|
20
+86%
|
24
+20%
|
22
-8%
|
29
+33%
|
28
-2%
|
33
+15%
|
30
-7%
|
25
-18%
|
|
Total Liabilities & Equity |
11
N/A
|
15
+32%
|
25
+70%
|
34
+39%
|
33
-5%
|
39
+18%
|
40
+4%
|
44
+10%
|
45
+1%
|
44
-2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
3
|
3
|
5
|
5
|
6
|
7
|
7
|
8
|
8
|
8
|